Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil is an effective and safe treatment for common hair loss when applied to the skin, but more research is needed for optimal use.

Derinat may improve hair growth and quality of life in hair loss patients by reducing oxidative stress.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Exosomes may improve skin, scars, hair growth, and fat grafts in plastic surgery, but more research is needed.

Kerascalp hair serum was found to be safe and effective in improving hair growth and strength in people with mild to moderate hair loss.

Low oxygen conditions improve how well certain stem cells from embryos can make hair grow longer and faster.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

Stress can cause temporary hair loss, which usually gets better after the stress is gone.

Hair shedding that lasts more than 6 months may need medical tests, but often just reassurance is enough.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

JAK inhibitors offer new hope for treating severe alopecia areata.

Using platelet-rich plasma injections and 5% minoxidil topically can safely and effectively treat mild-to-moderate male pattern baldness.

HX109 herbal extract helps hair grow by boosting cell growth and reducing cell death.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Umbilical cord cells safely improve healing in long-term nonhealing wounds better than a placebo.

Reassurance and counseling are key in managing acute telogen effluvium, with supplements possibly offering a placebo effect.

Melanocyte transplantation can safely restore skin color, especially in stable vitiligo, but must be chosen carefully based on the disease phase.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Using 5% minoxidil foam twice daily can help regrow hair, especially in younger men aged 20-30.

Samcyprone ointment is effective for treating common warts if a sensitization reaction occurs first.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

New drug shows promise for better hair growth in baldness treatment.

New oral treatment, finasteride, effectively and safely treats common hair loss.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Nourkrin® significantly increased hair growth and was well-tolerated by people with hair loss.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Minoxidil not effective in preventing chemotherapy-induced hair loss.